|Day Low/High||156.32 / 160.66|
|52 Wk Low/High||125.84 / 197.00|
- Study met primary endpoint demonstrating that higher doses of BOTOX® Cosmetic produce greater duration of treatment effect -
-- Allergan Medical Aesthetics Business Has Potential to Double by 2025 Driven by Consumer Trends, Geographic Expansion and Innovation --
- Acquisition Adds Fast-Acting Neurotoxin Programs with 2 to 4-Week Duration to Allergan's Best-in-Class Medical Aesthetics Portfolio and Pipeline -
Spotlyte marks the first launch from Allergan digital ventures unit, Project Moonwalker™
DUBLIN, Sept. 10, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it will host a Medical Aesthetics Day event and webcast on Friday, September 14, 2018.
NOVEL, DUAL-ACTING PRODUCT REVITALIZES AND PROTECTS SKIN AGAINST BLUE LIGHT AND ENVIRONMENTAL AGRESSORS AROUND THE CLOCK
The entrance of more competition for Botox Cosmetic could expand the market, the drugmaker's top executive says at the Wells Fargo Healthcare Conference in Boston.
DUBLIN, Sept. 4, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Morgan Stanley Global Healthcare Conference in...
DUBLIN, Aug. 30, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Wells Fargo Healthcare Conference in Boston,...
-- Director Paul Bisaro to Retire from Allergan Board --
Today, US subsidiaries of Aegon reached a settlement with the Securities and Exchange Commission (SEC) in the matter of the operation and implementation of asset management quantitative models by Aegon's US asset management operations, and related...
A 'bullish perfect storm of technical factors' is powering the recent strength in large-cap pharma stocks, says Evercore ISI's Rich Ross.
Here's what you need to know now for Thursday, Aug. 23.
DUBLIN, Aug. 21, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it received a Complete Response Letter (CRL) from the U.
Let's check out the charts again so see how far this advance might carry.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGN, DSS, ENDP, ICUI, PIH, SPB, SPPI, WAAS, YRD Downgrades: BMA, BRT, ELSE, FRBK, HAE, HSKA, JD, MATW, TCMD, TSG Initiations: ALT, TRTX Read on to get TheStreet Quant Ratings' detailed report:
There's too much evidence of economic strength, so don't interpret these moves as a sign of a real slowdown.
Net income amounts to EUR 491 million supported by increase in underlying earnings Underlying earnings increase by 2% to EUR 1,064 million, or 10% on constant currencies driven by expense savings, a higher investment margin in the Netherlands, performance...
Aegon has agreed to sell its businesses in Czech Republic and Slovakia for EUR 155 million to NN Group.
The Dow Jones Industrial Average declined by 125 points on Monday.
The first is the ISE Equity Ratio which chimed in at 213%, its first reading over 200% since January 26.
- Five New Board Members Added in Last 18 Months -
Reinforces both Allergan's and Editas' continued commitment to developing innovative treatments for unmet needs in eye care
This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.
These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.
We are looking at today's rotation as an opportunity to pick up a high-quality name at a discount.
-- Dividend to be Paid on September 17, 2018 --
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.